1-4 of 4
desmopressin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

Nathan T. Connell, Veronica H. Flood, Romina Brignardello-Petersen, Rezan Abdul-Kadir, Alice Arapshian, Susie Couper, Jean M. Grow, Peter Kouides, Michael Laffan, Michelle Lavin, Frank W. G. Leebeek, Sarah H. O’Brien, Margareth C. Ozelo, Alberto Tosetto, Angela C. Weyand, Paula D. James, Mohamad A. Kalot, Nedaa Husainat, Reem A. Mustafa
Journal: Blood Advances
Blood Adv (2021) 5 (1): 301–325.
https://doi.org/10.1182/bloodadvances.2020003264
Published: 2021
Includes: Supplemental data
Journal Articles

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD

Clinical Trials & Observations
Ferdows Atiq, Lisette M. Schütte, Agnes E. M. Looijen, Johan Boender, Marjon H. Cnossen, Jeroen Eikenboom, Moniek P. M. de Maat, Marieke J. H. A. Kruip, Frank W. G. Leebeek
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4147–4154.
https://doi.org/10.1182/bloodadvances.2019000863
Published: 2019
Journal Articles

New therapies for von Willebrand disease

Pier Mannuccio Mannucci
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3481–3487.
https://doi.org/10.1182/bloodadvances.2019000368
Published: 2019
Journal Articles

A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding

Clinical Trials & Observations
Victoria Candy, Hilary Whitworth, Julie Grabell, Lisa Thibeault, Lori Harpell, Mackenzie Bowman, David Good, Wilma M. Hopman, Robert F. Sidonio, Jr, Paula D. James
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2629–2636.
https://doi.org/10.1182/bloodadvances.2018023713
Published: 2018